Skip to main content

Advertisement

Log in

Genetic interaction analysis of VEGF-A rs3025039 and VEGFR-2 rs2071559 identifies a genetic profile at higher risk to develop nodular goiter

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Context

Nodular goiter in patients from areas of iodine deficiency is due to the growth of follicular and endothelial cells, involving different vascular-related growth factors in its pathogenesis.

Objective

The aim of our study was to examine the association of known single polymorphisms of vascular endothelial growth factor-A [VEGF-A], VEGF receptor-2 [VEGFR-2] and hypoxia-inducible factor-1α [HIF-1α] genes or their genetic interactions with the risk of nodular goiter development.

Patients and methods

116 normal subjects, without any thyroid disease, and 108 subjects with nodular goiter [subjects with goiter and at least one thyroid nodule of > 1 cm of maximum size and in absence of signs of autoimmunity] were selected from a homogeneous population living in a mild iodine deficiency geographic area. Analyses were performed on germline DNA obtained from blood samples and VEGF-A rs3025039, VEGFR-2 rs2071559, and HIF-1αrs11549465 SNPs were investigated by real-time PCR technique. The multifactor dimensionality reduction [MDR] methodology was applied to investigate the genetic interaction between SNPs. Hardy–Weinberg equilibrium was performed.

Results

None of the studied polymorphisms were individually associated with a higher risk to develop nodular goiter [P > 0.05]. The combination of the VEGF-A rs3025039 and VEGFR-2 rs2071559 polymorphisms had the highest accuracy of 0.58 [P = 0.018] and the interaction of some genotypes was significantly associated with the risk of nodular goiter development.

Conclusions

Our results support a genetic interaction between the VEGF-A rs3025039 and VEGFR-2 rs2071559 polymorphisms as a predictor of the risk to develop nodular goiter in subjects coming from an area with mild iodine deficiency.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Tonacchera M, Pinchera A, Vitti P (2010) Assessment of nodular goitre. Best Pract Res Clin Endocrinol Metab 24:51–61

    Article  CAS  Google Scholar 

  2. Ramsden JD (2000) Angiogenesis in the thyroid gland. J Endocrinol 1663:475–480

    Article  Google Scholar 

  3. Denef JF, Ovaert C, Many MC (1989) Experimental goitrogenesis. Ann Endocrinol 50:1–15

    CAS  Google Scholar 

  4. Dumont JE, Lamy F, Roger P, Maenhaut C (1992) Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev 72:667–697

    Article  CAS  Google Scholar 

  5. Knudsen N, Laurberg P, Perrild H, Bülow I, Ovesen L, Jørgensen T (2002) Risk factors for goiter and thyroid nodules. Thyroid 12:879–888

    Article  Google Scholar 

  6. Wollman SH, Herveg JP, Zeligs JD, Ericson LE (1978) Blood capillary enlargement during the development of thyroid hyperplasia in the rat. Endocrinology 103:2306–2312

    Article  CAS  Google Scholar 

  7. Peach CJ, Mignone VW, Arruda MA, Alcobia DC, Hill SJ, Kilpatrick LE, Woolard J (2018) Molecular Pharmacology of VEGF-A Isoforms: binding and signalling at VEGFR2. Int J Mol Sci 19(4):1264

    Article  Google Scholar 

  8. Davis PJ, Sudha T, Lin HY, Mousa SA (2015) Thyroid hormone, hormone analogs, and angiogenesis. Compr Physiol 6:353–362

    Article  Google Scholar 

  9. Turner HE, Harris AL, Melmed S, Wass JA (2003) Angiogenesis in endocrine tumors. Endocr Rev 245:600–632

    Article  Google Scholar 

  10. Jun JC, Rathore A, Younas H, Gilkes D, Polotsky VY (2017) Hypoxia- inducible factors and cancer. Curr Sleep Med Rep 31:1–10

    Article  Google Scholar 

  11. Aghini Lombardi F, Fiore E, Tonacchera M, Antonangeli L, Rago T, Frigeri M, Provenzale AM, Montanelli L, Grasso L, Pinchera A, Vitti P (2013) The effect of voluntary iodine prophylaxis in a small rural community: the Pescopagano survey 15 years later. J Clin Endocrinol Metab 3:1031–1039

    Article  Google Scholar 

  12. Pasqualetti G, Danesi R, Del Tacca M, Bocci G (2007) Vascular endothelial growth factor pharmacogenetics: a new perspective for anti-angiogenic therapy. Pharmacogenomics 8:49–66

    Article  CAS  Google Scholar 

  13. Wang Y, Zheng Y, Zhang W, Yu H, Lou K, Zhang Y, Qin Q, Zhao B, Yang Y, Hui R (2007) Polymorphisms of KDR gene are associated with coronary heart disease. J Am Coll Cardiol 50:760–767

    Article  CAS  Google Scholar 

  14. Hu X, Fang Y, Zheng J, He Y, Zan X, Lin S, Li X, Li H, You C (2014) The association between HIF-1α polymorphism and cancer risk: a systematic review and meta-analysis. Tumour Biol 35:903–916

    Article  CAS  Google Scholar 

  15. Excoffier L, Laval G, Schneider S (2007) Arlequin: an integrated software package for population genetics data analysis. Evol Bioinform Online 1:47–50

    PubMed  PubMed Central  Google Scholar 

  16. Moore JH, Gilbert JC, Tsai CT, Chiang FT, Holden T, Barney N, White BC (2006) A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J Theor Biol 241:252–261

    Article  Google Scholar 

  17. Hegedüs L, Bonnema SJ, Bennedbaek FN (2003) Management of simple nodular goiter: current status and future perspectives. Endocr Rev 24:102–132

    Article  Google Scholar 

  18. Knudsen N, Bülow I, Laurberg P, Ovesen L, Perrild H, Jørgensen T (2002) Association of tobacco smoking with goiter in a low-iodine-intake area. Arch Intern Med 162:439–443

    Article  Google Scholar 

  19. Rotondi M, Amato G, Biondi B, Mazziotti G, Del Buono A, Rotonda Nicchio M, Balzano S, Bellastella A, Glinoer D, Carella C (2000) Parity as a thyroid size-determining factor in areas with moderate iodine deficiency. J Clin Endocrinol Metab 85(12):4534–4537

    Article  CAS  Google Scholar 

  20. Brix TH, Kyvik KO, Hegedüs L (1999) Major role of genes in the etiology of simple goiter in females: a population-based twin study. J Clin Endocrinol Metab 84:3071–3075

    CAS  PubMed  Google Scholar 

  21. Malamos B, Koutras DA, Kostamis P, Rigopoulos GA, Zerefos NS, Yataganas XA (1967) Endemic goitre in Greece: a study of 379 twin pairs. J Med Genet 4:16–18

    Article  CAS  Google Scholar 

  22. Westermark K, Karlsson FA, Westermark B (1983) Epidermal growth factor modulates thyroid growth and function in culture. Endocrinology 112:1680–1686

    Article  CAS  Google Scholar 

  23. Cowin AJ, Davis JR, Bidey SP (1992) Transforming growth factor-β production in porcine thyroid follicular cells: regulation by intrathyroidal organic iodine. J Mol Endocrinol 9:197–205

    Article  CAS  Google Scholar 

  24. Logan A, Black EG, Gonzalez AM, Buscaglia M, Sheppard MC (1992) Basic fibroblast growth factor: an autocrine mitogen of rat thyroid follicular cells? Endocrinology 130:2363–2372

    Article  CAS  Google Scholar 

  25. Becks GP, Logan A, Phillips ID, Wang JF, Smith C, DeSousa D, Hill DJ (1994) Increase of basic fibroblast growth factor [FGF] and FGF receptor RNA during rat thyroid hyperplasia: temporal changes and cellular distribution. J Endocrinol 142:325–338

    Article  CAS  Google Scholar 

  26. Hill DJ, Phillips ID, Wang JF, Becks GP (1994) Basic fibroblast growth factor [basic FGF] in isolated ovine thyroid follicles: thyrotropin stimulation and effects of basic FGF on DNA synthesis, iodine uptake and organification and the release of insulin-like growth factors [IGFs] and IGF binding proteins. Thyroid 4:77–85

    Article  CAS  Google Scholar 

  27. Many MC, Denef JF, Haumont S (1984) Precocity of the endothelial proliferation during a course of rapid goitrogenesis. Acta Endocrinol 105:487–491

    Article  CAS  Google Scholar 

  28. Ramsden JD, Buchanan MA, Egginton S, Watkinson JC, Mautner V, Eggo MC (2005) Complete inhibition of goiter in mice requires combined gene therapy modification of angiopoietin, vascular endothelial growth factor, and fibroblast growth factor signaling. Endocrinology 146:2895–2902

    Article  CAS  Google Scholar 

  29. Liu R, Ning L, Liu X, Zhang H, Yu Y, Zhang S, Rao W, Shi J, Sun H, Yu Q (2017) Association between single nucleotide variants of vascular endothelial growth factor A and the risk of thyroid carcinoma and nodular goiter in a Han Chinese population. Oncotarget 28:15838–15845

    Google Scholar 

  30. Kilic I, Guldiken S, Sipahi T, Palabiyik O, Akker M, Celik O, Soysal-Atile N, Tuncbilek N, Guven HM, Gundogdu AS, Sut N (2016) Investigation of VEGF and IL-8 gene polymorphisms in patients with differentiated thyroid cancer. Clin Lab 62:2319–2325

    Article  CAS  Google Scholar 

  31. Marotta V, Sciammarella C, Capasso M, Testori A, Pivonello C, Chiofalo MG, Pivonello R, Pezzullo L, Botti G, Colao A, Faggiano A (2017) Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib. Endocrine 3:539–543

    Article  Google Scholar 

  32. Bingül İ, Vural P, Doğru-Abbasoğlu S, Çil E, Uysal M (2017) Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma. J Clin Lab Anal 31(6):e22110

    Article  Google Scholar 

  33. Vural P, Baki M, Doğru-Abbasoğlu S, Özderya A, Karadağ B, Uysal M (2012) Vascular endothelial growth factor polymorphisms increase the risk of developing Graves' disease. Int Immunopharmacol 14:133–137

    Article  CAS  Google Scholar 

  34. Salajegheh A, Smith RA, Kasem K, Gopalan V, Nassiri MR, William R, Lam AK (2011) Single nucleotide polymorphisms and mRNA expression of VEGF-A in papillary thyroid carcinoma: potential markers for aggressive phenotypes. Eur J Surg Oncol 37:93–99

    Article  CAS  Google Scholar 

  35. Hsiao PJ, Lu MY, Chiang FY, Shin SJ, Tai YD, Juo SH (2007) Vascular endothelial growth factor gene polymorphisms in thyroid cancer. J Endocrinol 195:265–270

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The study has been funded by a grant from the University of Pisa to GB and MT. The authors declare no conflict of interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Tonacchera.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.

Ethical approval

The study was conducted in accordance with National and International Ethical Standards for studies involving human subjects.

Informed consent

Informed consent was obtained from all subjects involved.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Molinaro, A., Orlandi, P., Niccolai, F. et al. Genetic interaction analysis of VEGF-A rs3025039 and VEGFR-2 rs2071559 identifies a genetic profile at higher risk to develop nodular goiter. J Endocrinol Invest 43, 149–155 (2020). https://doi.org/10.1007/s40618-019-01092-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-019-01092-9

Keywords

Navigation